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Summary
Human immunodeficiency virus (HIV) infection leads to a progressive loss of CD4+ T helper
(Th) type 1 cell-mediated immunity that is associated with defective in vitro CD4+ T cell pro-
liferation and abnormal T cell death by apoptosis in response to T cell receptor (TCR) stimula-
tion. Quantification of interleukin (IL)-2, interferon y, IL-4, IL-5, and IL-10 secretion by im-
munoassays, and of interferon y, IL-4 and IL-10 messenger RNA expression by competitive
reverse transcriptase polymerase chain reaction after in vitro stimulation of the TCR revealed a
similar Th1 cytokine profile in T cells from HIV-infected persons and from controls. These
data indicated that the loss ofCD4+ Thl cell function in HIV-infected persons is not related to
a Thl to Th2 cytokine switch as previously proposed, but to a process of activation-induced
death of CD4+ Thl cells. Despite the absence ofelevated levels of Th2 cytokines, apoptosis of
CD4+ T cells, but not of CD8+ T cells, was prevented in vitro by antibodies to IL-10 or IL-4,
two Th2 cytokines that downregulate Thl cell responses, or by the addition of recombinant
IL-12, a cytokine that upregulates Thl functions. TCR-induced apoptosis of T cell hybrido-
mas and preactivated T cells has been shown to involve the CD95 (Fas/Apo-1) molecule.
CD4+ and CD8+ T cells from HIV-infected persons expressed high levels of the CD95 mole-
cule, and, in contrast to T cells from controls, were highly sensitive to antibody-mediated CD95
ligation, which induced apoptosis in a percentage of T cells similar to that induced by TCR
stimulation. As TCR-induced apoptosis, CD95-mediated apoptosis of CD4+ T cells, but not
ofCD8+ T cells, was prevented by the addition of recombinant IL-12. Together, these findings
suggest that apoptosis ofCD4+ T cells from HIV-infected persons involves an abnormal sensi-
tivity to CD95 ligation, and to TCR stimulation in the presence of normal levels of Th2 cyto-
kines. The preventive effect ofIL-12 on both mechanisms has potential implications for the design
ofimmunotherapy strategies aimed at the upregulation ofCD4+ Thl cell functions in AIDS.
I
n HIV-1-infected persons, CD4+ T cell depletion is
preceded by early functional defects ofcell-mediated im-
munity (1-3), characterized in vitro by a failure of T cells
to proliferate in response to TCR stimulation by recall anti-
gens and by various mitogens, and in vivo by a loss o£ cell-
mediated, delayed-type hypersensitivity reaction, a response
Part of this work has been presented at the Third International Confer-
ence on Cytokines: Basic Principles and Practical Applications, Florence,
Italy, 28-30 March 1994, and at the First International Symposium on
HIV and Cytokines, Reims, France, 15-17 March 1995.
that involves the CD4+ Thl lymphocyte population (3).
We have proposed that T cell defects in HIV-1-infected
persons may be related to abnormal induction of apoptosis,
or programmed cell death (PCD)t caused by interference of
HIV mediated with intercellular signalling (4) . Experimen-
tal support for this model has been provided by a series of
observations from several laboratories showing abnormal
'Abbreviations used in this paper: CSA, cyclosporin A; CHX, cyclohexi-
mide; PCD, programmed cell death; RT-PCR, reverse transcriptase
PCR; SEB, Staphylococcal enterotoxin B.
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HIV-infected persons (5-11), as well as a relationship be-
tween HIV infection and PCD in mature CD4+ T cells,
thymocytes, and hematopoietic progenitor cells (12-20).
Candidate mechanisms for T cell apoptosis in response to
TCR stimulation include the ligation of the CD95 (Fas/
Apo-1) cell-surface molecule (21-23), involving the ex-
pression of CD95, the expression of the CD95 ligand, and
the induction of a differentiation stage that renders T cells
sensitive to CD95 ligation (24-29).
In a model that addressed the pathogenesis of cell-medi-
ated immunity defects independently of the question of T
cell death, Clerici and Shearer proposed that, as in other
chronic parasite bacterial or viral infections (30-33), the
progression of HIV infection to disease may result from a
progressive shift of CD4+ T cells from the Thl to the Th2
phenotype, leading to a loss of IL-2 and IFN-y production,
concomitant with increases in IL-4 and IL-10 secretion
(34). Consistent with this idea, in vitro addition ofIL-12, a
cytokine that favors the induction of a Thl cell response
(35), or of antibodies to IL-10 or IL-4, two cytokines that
inhibit Thl cell responses and favor the induction of a Th2
cell response (36), were shown to restore, in HIV-infected
persons, the proliferative response of T cells in response to
recall antigens and mitogens (37, 38). In this study, we
have explored the possibility that cytokines may affect T
cell functions by regulating apoptosis in T cells from HIV-
infected persons. Our results indicate that the defective
CD4+ Thl cell response in HIV infection is not related to
a Thl to Th2 cytokine switch, but to a process of activa-
tion-induced CD4+ Thl cell death by apoptosis in re-
sponse to normal levels of Th2 cytokines and to CD95
(Fas/Apo1) ligation, which can be prevented by the addi-
tion of IL-12.
Materials and Methods
Reagents, Antibodies, and Cytokines.
￿
Murine anti-human mAb
used were CD4 (Leu 3a, Becton Dickinson & Co., Mountain
View, CA); CD8 (Leu 2a; Becton Dickinson); CD14 (IOM2) ;
CD19 (10134) ; CD56 (IOT56); CD95 (UBZ); HLA class II
(IOT2a); and CD3 (IOT3b) (Immunotech, Marseille, France).
Purified azide-free rat anti-human cytokine neutralizing IgG1
mAb included anti-IL-10 (JES3-9137), anti-IL-4 (MP4-25132),
anti-IL-5 (TRFK5) (PharMingen, San Diego, CA), and purified
azide-free murine anti-human CD95 IgM mAb (CHtt) and con-
trol IgM mAb (GC3Z3) (Immunotech). Other reagents were Staphy-
lococcal enterotoxin B (SEB) (Toxin Technology Inc., Madison,
WI); PHA, PWM, cycloheximide (CHX) (Sigma, La Verpilliere,
France); cyclosporin A (CSA) (Sandimmum, Sandoz, Rueil Mal-
maison, France), acridine orange dye (Immunotech), and YO-
PRO-1 dye (Molecular Probes, Inc., Eugene, OR). Cytokines in-
cluded rIL-12 and rIL 10 (R&D Systems, Abingdon, UK), and
rIL-2, kindly provided by Roussel-UCLAF (Paris, France).
Cells and Culture Conditions.
￿
Heparinized venous peripheral
blood was obtained from HIV-1-seropositive adults with CD4+
T cell counts ranging from 100 to 1,500/tnm3 (mean = 560 -- 1-
363) and from HIV-seronegative healthy controls. PBMC were
isolated from heparinized venous blood by Ficoll-Hypaque den-
sity gradient centrifugation, and were cultured in RPMI 1640
(Gibco, Courbevoie, France) supplemented with 10% heat-inac-
tivated FCS (Boehringer Mannheim, Meylan, France), 2 mM
L-glutamine, 1 mM sodium pyruvate (Gibco), and gentamicin
(Gentalline; 8 NLg/ml, Schering-Plough, Levallois-Perret, France) .
In some experiments, PBMC were depleted of B cells and of ei-
ther CD4+ or CD8+ T cells by negative selection using CD19,
CD56, CD4, or CD8 mAb, and magnetic beads coated with
anti-mouse IgG (Dynal, Great Neck, NY), as described (11).
Contaminating CD4+ or CD8+ T cells were <5%, as assessed by
flow cytofluorometry (Epics Profile; Coulter Coultronics, Mar-
gency, France) . Cells were cultured in 96-well culture plates (Fal-
con; Becton Dickinson) at 2.5 X 105/ml, or at 106/ml in 24-well
plates forcytokine detections (Nunc, Roskilde, Denmark) . ForT
cell activation, stimuli used were PWM (10 ltg/ml), SEB (1 N.g/
ml), PHA (5 [ .g/ml), and CD3 mAb (0.5 N.g/ml). When added
to the cultures, mAbs against the IL-4, IL-5, and IL-10 cytokines
were used at 5 l.tg/ml, rIL-12 at 20 ng/ml, rIL-10 at 10 ng/ml,
and rIL-2 at 20 IU/ml, CSA at 0.5 LL/ml, and CHX at 0.2 ILg/
ml. The effect of CD95 cross-linkingwas explored by incubating
cells with the CD95 mAb CHI , (1 .5 NLg/ml) (28) or with the
control IgM mAb GC1Z3 (1.5 Lt.g/ml) .
Apoptosis Measurement and Sorting of Living Cells.
￿
Percentages
ofapoptotic cells were measured in duplicate under the light mi-
croscope by two different investigators. Cells counted as apop-
totic included cells with characteristic nuclear chromatin conden-
sation and fragmentation, as well as already dead cells that had lost
trypan blue exclusion capacity, as previously described (11) . Per-
centagemeasurement variation between the two investigators was
<1%. Percentages of cell death prevention, when so mentioned,
were expressed as follows:
apoptosis in apoptosis in
stimulated cells - stimulated cells with
mAb or cytokines
apoptosis in
￿
r apoptosis in
stimulated cells - \unstimulated cells
X 100
Percentages ofapoptotic cells countedunderthe light microscope
were confirmed by flow cytofluorometry analysis after incubation
with the nuclear dye acridine orange as described (11), or with
the nucleardyeYO-PRO-1, which does notaffect the functional
properties ofliving cells (50). After incubation with YO-PRO-1
(5 [LM for 106 cells) for 10 min, lymphocytes were gated under
forward and side light scatter, apoptotic cells representing two
peaks of high fluorescence intensity, and reduced forward scatter.
After stimulation with PWM, living lymphocytes were separated
from apoptotic lymphocytes with >98% efficiency, using cell
sorting coupled with flow cytofluorimetry analysis (Epics Elite
cell sorter; CoulterCoultronics). In contrast to theacridine orange
or Hoechst 33342 (Sigma) nuclear dyes, YO-PRO-1 only stains
apoptotic cells and is excluded by living cells, allowing further
functional studies to be performed on living cells (50). In an ex-
periment, autologous adherent accessory cells (2 X t05/ml) were
addedto theliving lymphocytes (I06/ml) sorted 36 hafter stimu-
lation with PWM, and cells were restimulated by PHA for an ad-
ditional 36 h culture.
Cytokine Detection.
￿
Immunoassays used for the determination
of cytokine secretion were ELISA Kits for IL-2, IL-4, and IL-12
(R&D Systems), IFN--y (Genzyme, Cambridge, MA), and IL-10
(Biosource, Camarillo, CA). IL-5 was determined using a pair of
rat anti-human IL-5 mAb (TRFK5, andJES1-5A10) (PharMin-
gen) in a two-site sandwich ELISA.
Quantification of Cytokine mRNA by Reverse Transcriptase Poly-
merase Chain Reaction (RT-PCR).
￿
Total cellular RNA was ex-
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RNAzol technique according to manufacturer's recommendations
(Bioprobe, Montreuil, France) and then extracted by phenol/
chloroform procedure . cDNAswere synthesized by adding to the
mRNA preparation 200U ofMoloney murine leukemia virus re-
verse transcriptase (GIBCO BRL, Cergy Pontoise, France) in the
presence ofoligo-dT 12_ 1s (Gibco-BRL) anddNTP. Samples were
incubated at 42 °C for60 min .
cDNA (50 ng) was incubated with (3-actin sense (5'-GGGT-
CAGAAGGATTCCTATG-3') and antisense (5'-GGTCTC-
AAACATGATCTGGG-3') primers, Taq polymerase (Bio-
probe), the 4 dNTP, 0.1 p,Ci ofdTTP 32P (Amersham, Les Ulis,
France), 25 mM MgCl? , and graded concentrations (0.01, 0.1,
and 1 pg) of a competitor (pQB2) (39, 40) . PCR was then per-
formed, each cycle consisting of 94°C, 1 min, 57°C, 1 min, and
72 °C, 1.5 min . The products of 31 cycles were electrophoresed
on a 2% agarose gel that was dried and autoradiographed for 3 h .
The intensities of the 237- and the 388-bp bands (corresponding
to the amplified (3-actin cDNA and to the amplified competitor, re-
spectively) were determined using an image analyzer (IMSTAR,
Paris, France), and their ratio was calculated. A curveofthe ratios
was established according to the competitor concentration for which
a similar amount of competitor and cDNA were present . Results
were expressed as the number of R-actin cDNA molecules present
in each sample .
Quantitation of cytokine cDNAs was then performed as fol-
lows . For IFN-y (sense, 5'-GCAGAGCCAAATTGTCTCCT-
3' ; antisense, 5'-ATGCTCTTCGACCTCGAAAC-3'), IL-10
(sense, 5'-AAATTTGGTTCTAGGCCGGG-3' ; antisense, 5'-
GAGTACAGGGGCATGATATC-3'), IL-4 (sense, 5'-T000TC-
CAAGAACACAACTG-3' ; antisense 5'-AACGTACTCTGG-
TTGGCTTC-3'), and IL-12 p40 chain (sense, 5'-ATTGAG-
GTCATGGTGGATGC-3' ; antisense, 5'-AATGCTGGCATT-
TTTGCGGC-3') cDNAs, a competitive PCR was performed by
adding to a volume of cDNA preparation containing 10 5 mole-
cules of (3-actin cDNA and graded concentrations of competitor
(39, 40) . For IL-12 p35 cDNA (sense, 5'-G000TGTGCCTT-
AGTAGTAT-3'; antisense, 5'-GCTCGTCACTCTGTCAATAG-
3'), a semiquantitative PCR was performed : fourfold dilutions of
cDNA were amplified in the same conditions as described above
except that no competitor was added . To express results, an arbi-
trary value of 1 was attributed to the amount of IL-12 p35 chain
cDNA present in the sample from unstimulated PBMC from the
healthy individual .
Statistical Analyses .
￿
Statistical significance was assessed by ei-
ther Student's t test or paired Student's t test, as mentioned .
Results and Discussion
Activation-induced T Cell Death Is Associated with a Th 1
Cytokine Secretion Profile . T cells from HIV-infected per-
sons undergo in vitro death by apoptosis, a process that is
markedly enhanced byTCR stimulation with PWM (Fig .
1 A), bacterial superantigens, or the CD3 mAb (5-11) . In
the present study, secretion of IL-2, IFN-y, IL-10, IL-4,
and IL-5 was compared in PBMC from HIV-infected per-
sons with those from uninfected controls in the absence of
any stimulation and after stimulation with PWM. In the ab-
sence of stimulation, the only cytokine secreted was IL-10,
but not significant differences were observed between lev-
els of spontaneous IL-10 released for 24 h by PBMC from
HIV-infected and -uninfected persons (not shown) . 24 h
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Figure 1 . Activation-induced cell death and cytokine secretion in
PBMC from HIV-1-infected individuals (40) or controls (O) . (A) Apop-
tosis was assessed under the light microscope 36 h after incubation with
medium orPWM. (B) IL-2, IL-10, and IFN-y secretions were measured
24 h after PWM stimulation. (C) IL-4 and IL-5 secretion were measured
24 h (1) or 40 h (2) after PWM stimulation . Dotted line represents signifi-
cant detection limit. Each circle represents results from a different study
subject . Bars represent the mean value in each group . Statistical signifi-
cance was assessed using Student's t test . NS, no significant differences be-
tween groups .
after activation, the secretion of IL-2, IFN-y, and IL-10 by
PBMC from HIV-infected persons and from controls was
at similar levels, with no significant differences (Fig. 1 B) .
24 and 40 h after stimulation, IL-4 and IL-5 secretion was
very low in PBMC from both HIV-infected persons and
controls, except for elevated IL-4 secretion in PBMC from
only 1 of the 16 HIV-infected persons (Fig. 1 C) . Quanti-
tative measurements of IFN-y, IL-4, and IL-10 mRNA
expression by competitive RT-PCR in PBMC from two
HIV-infected persons and one control confirmed the ab-
sence of elevated Th2 cytokine expression in the activated
T cells from HIV-infected persons (Table 1) .
Analysis of cytokine secretion by PBMC depleted either
of CD4+ or ofCD8+ T cell subsets showed that the Thl
cytokine IL-2 was secreted exclusively by the CD4+ T cells
(Fig . 2 A) . IL-2 secretion levels, although not significantly
different in HIV-infected and -uninfected persons, were
more variable among individuals in the HIV-infected group,
with some values being very low (Fig . 1 B) . We explored
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￿
Quantitative Analysis ofCytokine mRNA Expression
by Competitive RT-PCR
PBMC from two HIV-infected persons (HIV) and one control (CTR)
were incubated for 10 h in the absence (Med) or presence of PWM.
Results represent picograms ofIL-10, 10-3 pg of IFN-y, and 10-5 pg
of IL-4 cytokine mRNA expression for 105 molecules of (3-actin
mRNA.
whether this heterogeneity could be related to the hetero-
geneity of CD4+ T cell counts in the HIV-infected per-
sons. As shown in Fig. 2 B, when levels of IL-2 were ex-
pressed per 4 X 105 CD4+ T cells/ml, after correcting for
the variation in CD4+ T cell counts, IL-2 secretion by T
cells from HIV infected persons, although still heteroge-
nous, was found to be significantly higher than that of T
cells from controls. In additional experiments, living lym-
phocytes from one HIV-infected person and from a control
were separated from apoptosic lymphocytes 36 h after in
B 8000
6000-
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a
2000-
04
p<0.036
e
p<0.003
2
Figure 2.
￿
Cellular origin and kinetics ofcytokine secretion. (A) Cyto-
kine secretion in PBMC depleted either o£ CD8+ T cells (CD4) or of
CD4+ T cells (CD8) 24 h after PWM stimulation. (B) IL-2 secretion ex-
pressed per 4 X 105 CD4+ T cells, 24 h (1) or 40 h (2) after stimulation
with PWM of PBMC from HIV-infected persons (0) or controls (O).
Each circle represents a different individual.
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vitro stimulation with PWM, using cell sorting coupled to
flow cytofluorometry analysis (Fig. 3). After restimulation
ofthe surviving cellswith PHA for an additional 36 h, only
IL-2 and IFN-y were secreted, although at low levels, in
cells from the HIV-infected persons, and no IL-4 secretion
was observed (Fig. 3) . Together, these data suggest the sole
presence in HIV-infected persons of CD4+ T cells with a
Thl cell phenotype rather than the existence of a Thl to
Th2 cytokine switch, as previously proposed (34). Our
findings of a lack of increased Th2 cytokine secretion are
consistent with recent results from cytokine messager RNA
analysis in vivo in the lymph nodes of HIV-infected per-
sons (41) .
Preventive Effect ofIL-12 and ofAntibodies to IL-10 or IL-4
on Activation-induced Apoptosis of CD4+ TCells. Despite the
fact that the levels ofthe Th2 cytokines IL-10 and IL-4 ex-
pressed by activated PBMC from HIV-infected persons
were not superior to those expressed by activated PBMC
from controls, the addition of antibodies against the Th2
cytokines IL-10 or IL-4 had a statistically significant pre-
ventive effect on activation-induced apoptosis in PBMC
from HIV-infected persons (Fig. 4), while antibodies to the
Th2 cytokine IL-5 had no preventive effect (not shown) .
IL-10 and IL-4 have been shown to downregulate Thl cell
function by several means (36), including an inhibitory ef-
fect of IL-10 on monocyte/macrophage secretion of IL-12
(42), a cytokine that upregulates Thl cell function and
whose production has been reported to be impaired in
HIV-infected persons (43) . As shown in Fig. 4, addition of
rIL-12 also prevented activation-induced apoptosis in
PBMC from HIV-infected persons. Addition of the Thl
cytokine rIL-2 had a different effect, preventing spontane-
ous apoptosis, but not activation-induced apoptosis (not
shown), a situation in which IL-2 was already secreted (Fig.
1 B). Further experiments performed in PBMC depleted of
B cells, NK cells, and either CD4+ T cells or CD8+ T cells
indicated that, in contrast to drugs such as CSA and the
protein synthesis inhibitor cycloheximide, which showed
some preventive effect on apoptosis in both CD4+ and
CD8+ T cells from HIV-infected persons, the addition of
IL-12 or of antibodies to IL-10 or IL-4 had a preventive ef-
fect on activation-induced apoptosis in CD4+ T cells, but
not in CD8+ T cells, from HIV-infected persons (Figs. 5 A
and 6) .
The preventive effect of anti-IL-4 antibodies on CD4+
T cell death was less frequently observed than that ofrIL-12
or ofanti-IL-10 antibodies (Fig. 5 A) . In instances in which
anti-IL-4 antibodies did not prevent apoptosis, they did not
enhance the preventive effect of anti-IL-10 antibodies (Fig.
5 B), suggesting that IL-4 was involved in CD4+ T cell apop-
tosis induction in only some HIV-infected persons.
Cytokines have been shown to regulate T cell differenti-
ation and function by two different means: (a) cytokines
such as IL-2 and IL-12, or IL-4, act by inducing the differ-
entiation and expansion ofthe Thl or Th2 CD4+ cell pop-
ulation, respectively; (b) cytokines such as IL-10, IL-4, or
IFN-y, which can be secreted by accessory cells, play an
indirect role in Thl or Th2 expansion by downregulating
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measured 36 h after restimulation with PHA.
the converse Th cell population; IL-10 and IL-4 by inhib-
iting Thl cell expansion, and IFN--y by inhibiting Th2 cell
expansion (36, 44) . Our findings suggest that cytokine-
mediated regulation ofthe Thl cell response could also op-
erate through the control of T cell PCD, and that Th2 cyto-
kine-mediated Thl cell PCD may represent a mechanism
of Thl cell downregulation that is prevented by IL-12.
Our findings that IL-10 and IL-4 secretion (Fig. 1) and
IL-10 mRNA expression (Table 1) were similar in PBMC
from HIV infected persons and from controls, and that IL-4
mRNA expression was even lower in PBMC from HIV-
infected persons (Table 1), indicate that additional factors
act together with IL-10 and IL-4 in inducing apoptosis in
activated CD4+ Thl cells from HIV infected persons. An
obvious possibility suggested by our findings of a preven-
tive effect of exogenous IL-12 is that such an additional
factor is represented by the previously reported defect in
IL-12 secretion ofPBMC from HIV-infected persons (43) .
Quantitative measurement of the IL-12 p40 chain mRNA
by competitive RT-PCR showed a similar expression in
PWM-stimulated PBMC from two HIV-infected persons
and one control (Table 2) . Semiquantitative RT-PCR of
the IL-12 p35 chain mRNA revealed great variations, but
Figure 4.
￿
Preventive effect of anti-IL-4 mAb, anti-IL-10 mAb, and
HL-12 on activation-induced cell death. Apoptosis was measured in
PBMC from HIV-1-infected persons (") and from controls (O) 24 h af-
ter incubation with medium, PWM, or SEB, in the absence or presence
of anti-IL-4 mAb, IL-10 mAb, or rIL-12. Each circle represents a differ-
ent individual. Percentages of cell death prevention (cell recovery) were
calculated as described in Materials and Methods. Statistical significance
was assessed using paired Student's t test.
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10 mAb, and of rIL-12 on acti-
vation-induced death of CD4
cells from HIV-infected persons .
PBMC from HIV-1-infected
persons were depleted ofB, NK,
andCD8 T cells, and were incu-
bated for 36 h with PWM in the
absence or presence ofanti-IL-4
mAb, anti-IL-10 mAb, or IL-12 .
Each circle represents a different
individual. Statistical signifi-
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of either mAb directed against IL-4 or IL-10 (or a mixture of both), or with rIL-10 or IL-12 cytokines (or a mixture ofboth) . Background of apoptosis
in the absence ofPWM was <15%, and it was subtracted from the results .
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with opposite patterns in the two HIV-infected persons
(Table 2) . Finally, in the conditions of ourT cell activation
assays, we could not detect secretion of the active form of
the IL-12 p70 heterodimer in PWM-stimulated PBMC
from the two HIV-infected persons and the control . There-
fore, we do not know at this stage whether normal amounts
of the active form of IL-12 are secreted (and taken up) by
PBMC from HIV-infected persons, but are unsufficient to
prevent IL-10- or IL-4-mediated apoptosis, or whether
Table 2 .
￿
Analysis of Cytokine mRNA Expression by RT-PCR
IL-12
Patients
Quantitative analysis of IL-10 and IL-12 p40 mRNA expression was
performed by competitive RT-PCR ; IL-12 p35 mRNA expression
was measured by semiquantitative RT-PCR (see Materials and Meth-
ods) . PBMC from two HIV-infected persons (HIV)and one control
(CTR) were incubated for 10 h in the absence (Med) or presence of-
PWM (PWM), or they were incubated simultaneously with PWM and
rIL-12, or PWM and anti-IL-10 antibodies . Results represent pico-
grams of IL-10, 10-^ pg of IL-12 p40 cytokine mRNA expression for
10' molecules of (3-actin mRNA, and IL-12 p35 values are expressed
according to theamount of IL-12 p35 chain cDNA present in the sam-
ple from unstimulatedPBMC from the control individual .
PWM IL-4 IL-10 IL-4 IL-12 11,-10 IL-10
IL-10 IL-12
PBMC from HIV-infected persons indeed present a defect
in the secretion o£ the active form of IL-12 (43) .
Concerning the preventive effect of the addition of ex-
ogenous HL-12 on apoptosis, our findings suggest the in-
volvement of two synergistic mechanisms : a direct protec-
tive effect o£ rIL-12 on IL-10-mediated apoptosis (Fig . 6),
and a modest inhibitory effect of rIL-12 on IL-10 mKNA
expression (Table 2) . Together, our findings suggest that
IL-12 may play a major role in CD4+ Thl cell survival by
preventing IL-10- and IL-4-mediated apoptosis in re-
sponse to TCR stimulation . After our manuscript was sub-
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Comparative effect of cytokines and drugs on activation-
induced death of CD4+ and CD8+ T cells . PBMC from an HIV-1-
infected person and a control were depleted ofB, NK, and either CD8+
(") or CD4+ T cells (O), and were incubated for 36 h with medium,
PWM, or CD3 mAb in the absence (1) or presence of CSA (2), CHX
(3), rIL-12 (4), anti-IL-10 mAb (5), or anti-IL-4 mAb (6) . These results
are from one representative experiment out offour .
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50
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Meet 39 0.3 0.01 40
PWM 129 62 0.5 30
PWM rIL-12 62 73 14 20
PWMmAb IL-10 121 59 14mitted for publication, a recent publication confirmed that
apoptosis of activated T cells from HIV-infected persons
can be prevented by the addition of antibodies to IL-10 or
IL-4, or by the addition of rIL-12 (45) . This publication
differs, however, from our findings in several important
ways . First, it reports that anti-IL-10 or anti-IL-4 antibod-
ies and rIL-12 treatment have the same preventive effect on
apoptosis of both CD4+ and CD8+ T cells ; second, the
complexity of the stimuli used to induce T cell apoptosis (a
mixture ofPWM and SEB) renders interpretation of the
results difficult ; third, it describes an additional preventive
effect of rIL-2 on activation-induced T cell apoptosis ; fi-
nally, it attributes the preventive effect of Thl cytokines
and of anti-Th2 cytokine antibodies on T cell apoptosis to
the existence of a Thl to Th2 cytokine switch in HIV-
infected persons . Our results clearly indicate that the pro-
gressive loss of cell-mediated Thl function in HIV-infected
persons can occur in the absence of a Th1 to Th2 cytokine
switch, and is related to the fact that the stimulation of
CD4+ Thl cells induces their rapid death by apoptosis in
response to normal levels of IL-10 and IL-4 . A progressive
loss of Thl CD4 + cells in the absence of a compensatory
expansion ofTh2 CD4+ cells could participate in the pro-
gressive CD4 + T cell dysfunction and depletion that lead to
AIDS . The recent finding that HIV-1 may preferentially
replicate in Th2 and Th0 CD4+ T cell clones, and not in
CD4+ Thl cell clones (46), provides-a possible mechanism
bywhich expansion ofCD4+ Th2 cells may be impaired in
HIV-1-infected persons .
Preventive Effect of IL-12 on CD95 (FaslApo-1)-mediated
Apoptosis ofCD4+ TCells . TCR activation-induced death
ofT cell hybridomas and ofpreactivated nontransformed T
cells has been recently shown to involve the CD95 cell-
surface receptor (21-23) . CD95-mediated apoptosis of T
cells does not only depend on the expression ofCD95 and
of the CD95 ligand, but also on the acquisition of a sensi-
tive phenotype to CD95-mediated apoptosis (28, 29, 47) .
As shown in Fig. 7 A, flow cytofluorometry analysis indi-
cated that the percentage of CD4+ and CD8+ T cells ex-
pressing cell-surface CD95, in the absence ofin vitro TCR
stimulation, was significantly higher in HIV-infected per-
sons than in controls. Antibody-mediated ligation ofCD95
induced high levels of apoptosis in PBMC and in both
CD4+ and CD8+ T cells from HIV-infected persons, but
not from controls (Fig . 7, B and C) . The percentage of
apoptosis induced by CD95 ligation in T cells from HIV-
infected persons was similar to that induced by TCR stim-
ulation (11) . The addition of rIL-12 had the same preven-
tive effect (-50%) on apoptosis induced by CD95 ligation
(Fig . 7 D) and byTCR stimulation (Fig . 5 A) in CD4+ T
cells from HIV-infected persons, but had only a very slight
preventive effect on CD8 + T cell apoptosis in response to
CD95 ligation (Fig. 7 D) . These findings suggest that IL-12
directly interferes with intracellular messengers, leading to
apoptotic death of CD4+ T cells from HIV-infected per-
sons . In T cells from controls, it has been shown that TCR
stimulation upregulates CD95 expression within 24 h, but
that the T cells are resistant to apoptosis in response to CD95
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(A) Percentages ofCD4+ and CD8+ T cells expressing the
CD95 (Fas) molecule . Flow cytofluorometry analysis was performed in
PBMC from HIV-infected persons (") and from controls (O) by using
FITC-labeled CD95 mAb and with phycoerythrin-labeled CD4 or CD8
mAb . CD4, percentages ofCD4+ T cells expressing CD95 ; CD8, per-
centages ofCD8+ T cells expressing CD95 . Each circle represents a dif-
ferent individual . Bars represent the mean value in each group . Statistical
significance was assessed using Student's t test. (B) Apoptosis in response
to CD95 (Fas) ligation . PBMC from an HIV-infected person (HIIJ and a
control (CTR) were incubated for 18 h with medium (Med) or CD95
IgM mAb (Fas) 18 h after incubation with medium (left) or CD95 IgM
mAb (right) . PBMC from an HIV-infected person (bottom) and a control
(top) were stained with the nuclear dye acridine orange, and apoptosis was
assessed using flow cytofluorometry analysis. The percentage of apoptotic
cells corresponding to the peak of reduced fluorescence intensity is indi-
cated in each experimental condition. (C) Apoptosis of CD4+ and CD8+
T cells in response to CD95 (Fas) ligation . PBMC from HIV-infected
persons (" ) and from controls (O) were depleted of either CD8+ T cells
(CD4) or ofCD4+ T cells (CD8), and were incubated for 18 h in the
presence (+) or absence (-) of the CD95 mAb (Fas IgM) . Each circle
represents a different individual . Statistical significance was assessed using
paired Student's t test . (D) Preventive effect of rIL-12 on CD95 (Fas)-
mediated apoptosis of CD4+ and CD8+ T cells . PBMC from HIV-
infected persons (") and from controls (O) were incubated for 18 h with
the CD95 niAb (Fas IgM) in the presence (+) or absence (-) of IL-12 .
IL-12 was added 30 min before the CD95 mAb . Each circle represents a
different individual. Significance was assessed using paired Student's t test .
Mean cell death prevention percentage (as in Figs . 4 and 5 A) of IL-12 on
CD95-mediated apoptosis was 48.8% in CD4+ T cells from HIV-infected
persons, and 8.6% in CD8+ T cells from HIV-infected persons .
ligation (28, 47) . Sensitivity to TCR- and CD95-mediated
apoptosis, which may involve a downregulation of the ex-
pression of Fas-associated tyrosine phosphatase FAP-1 (29),
occurs only after several days of culture and after several steps
ofTCR restimulation (28, 47, 48) . It is possible, therefore,
that the increased susceptibility of CD4+ Thl cells from
HIV-infected persons to TCR- and CD95-mediated apop-
tosis is related to a chronic in vivo activation of these CD4+
T cells . The preventive effect of anti-IL-10 and anti-IL-4
antibodies on TCR activation-induced apoptosis ofCD4+
T cells from HIV-infected persons suggests that these Th2cytokines mayparticipate in T cell death either by inducing
CD95 ligand expression or by maintaining CD95 sensitiv-
ity in TCR-activated CD4+ T cells in the absence of IL-
12. The precise mechanisms by which IL-12, IL-10, and
IL-4 regulate apoptosis of CD4 T cells from HIV-infected
persons, and the possibility that FAP-1 represents one of
the intracellular targets of such regulation, are currently un-
der investigation. In normal B cells, it has been recently
shown that defined activation signals canmodulate the sen-
sitivity to CD95-mediated apoptosis, CD40 ligation by in-
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